tradingview.comOCT 61 min read$STZ

Constellation Brands Non-GAAP EPS of $3.74 beats by $0.19, revenue of $2.63B beats by $90M

Constellation Brands reported Q2 Non-GAAP EPS of $3.74, exceeding estimates by $0.19. Revenue reached $2.63B, up 6.0% year-over-year, surpassing expectations by $90M. The company's Q3 revenue and EPS consensus are $2.22B and $2.82, respectively, with FY estimates at $9.09B and $11.71.

Original reporting

tradingview.com

Published Oct 6, 2026, 8:10 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 7, 2026, 6:15 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Constellation Brands Non-GAAP EPS of $3.74 beats by $0.19, revenue of $2.63B beats by $90M — source image — Source · tradingview.com

Decision brief

The 30-second read

$STZBullishMed

Why it matters

The earnings beat provides fresh data for traders to adjust positions ahead of after-hours trading.

Market read

Earnings beat offers a short-term trading opportunity for STZ.

What to watch

Future guidance is modest; investors may focus on upcoming Q3 outlook.

Relevance 8/10Novelty 8/10Timing: post-market

Background

Constellation Brands' Q2 results were released via a press release and aggregated by Seeking Alpha.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$STZBullishHigh confidence

Context

Constellation Brands reported Q2 Non-GAAP EPS of $3.74, beating expectations by $0.19 and revenue of $2.63B, up $90M.

Expected impact

likely upside as market prices in the earnings beat

Evidence & confidence

The beat is fresh primary disclosure; investors typically bid the stock on better-than-expected results.

Market effects

Sector

Positive earnings may lift the broader alcoholic beverages sector.

Regional

U.S. consumer discretionary stocks could see modest gains.

Global

Limited to markets tracking U.S. consumer staples.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face short-term profit taking.

Key entities

Company
Constellation Brands
U.S. alcoholic beverage producer.

Read at source ← All news

NOV 2

$STZMed

Jefferies raises Constellation Brands stock price target on beer margin outlook

Jefferies raised its price target for Constellation Brands (STZ) to $142 from $135, maintaining a Hold rating. The firm cited improved beer margin outlook and recent share gains. STZ's P/E ratio is 12.09, with a PEG ratio of 0.19. The company reported Q2 net sales of $2.63B, up 6% YoY, with EPS of $3.74. Other analysts have mixed outlooks.

investing.com2 min

OCT 31

$STZMed

Judge keeps distribution deal in place after Coors warns of nine-figure losses

A Denver judge blocked Constellation Brands from canceling its distribution deal with Coors Distributing Company (CDC), a subsidiary of Molson Coors, citing potential $100M+ losses and reputational harm. CDC claims the deal is worth over nine figures. Constellation disputes CDC's claims. A hearing on CDC's lawsuit against Mark Anthony Brands is scheduled.

denverpost.com2 min

OCT 12

$STZMedAI 8/10

Constellation Brands Agrees to Buy SpikedAde for Up to $353 Million

Constellation Brands (STZ) agreed to buy SpikedAde for up to $353M, entering the 'hard hydration' alcohol segment. The deal follows Q2 results showing beer sales growth but softer retail demand. CEO Nick Fink aims to diversify, though past acquisitions have underperformed. Analysts note the deal's manageable size but caution about the category's long-term potential.

vinetur.com7 min

OCT 12

$STZMedAI 8/10

Constellation Brands reports a 26% drop in first-half wine and spirits sales

Constellation Brands reported a 26% drop in wine and spirits net sales to $308.6M for the first half of its fiscal year, largely due to 2025 divestitures. Organic sales in the segment grew 12%. Group net sales rose 1% to $5.066B, with beer sales up 4% to $4.757B. Net income increased 24% to $1.220B. The company maintained a cautious outlook for the rest of the year.

vinetur.com2 min

OCT 11

$STZHighAI 8/10

Constellation Brands: Q2 Revenue Rises 6% To $2.63 Billion As Beer And Wine And Spirits Sales Grow

Constellation Brands reported Q2 fiscal 2027 net sales of $2.63B, up 6% YoY. Beer sales rose 5% to $2.47B, while Wine and Spirits sales increased 17% to $159.4M. Operating income fell 8% to $805M, but EPS rose 25% to $3.32. The company acquired SpikedAde for $75M, with up to $278M in contingent payments. Constellation updated its fiscal 2027 EPS guidance to $11.85-$12.55 and declared a $1.03 quarterly dividend.

pulse2.com3 min

OCT 9

$LWLow

Earnings market review: beats fall short as guidance and costs drive reactions

Lamb Weston (LW) and Constellation Brands (STZ) reported earnings beats but faced mixed reactions due to guidance and cost pressures. PepsiCo (PEP) and Delta Air Lines (DAL) also reported, with DAL missing EPS estimates. Analysts note that estimate revisions, not just beats, are driving market reactions. The macro backdrop includes high yields and expensive oil, impacting earnings expectations.

uk.investing.com3 min